FEops
IF WE revolutionize structural heart interventions, can we improve clinical outcome and accelerate time to market?

Challenge
Structural heart interventions remain highly complex, with outcomes often depending on how devices interact with each patient’s unique anatomy. Traditional approaches rely on basic anatomical measurements, which are insufficient to predict device behavior and patient response. This creates challenges for both manufacturers, who face long development timelines, and physicians, who need better tools to optimize treatment decisions and improve outcomes.

Disruptive Innovation
FEops is redefining structural heart interventions with cutting-edge technology that transforms cardiac images into digital twins—virtual copies of the heart or its substructures. This approach enables highly personalized treatment planning, helping physicians and MedTech companies alike make better decisions, reduce risks, and accelerate innovation.
At the core is the CE-marked FEops HEARTguide™, a unique, cloud-based platform that goes beyond traditional anatomical measurement. By combining digital twins with AI-enabled anatomical analysis, HEARTguide™ delivers data-driven insights that improve procedure planning, efficiency, and outcomes.
Key Innovations
- Transforming cardiac images into digital twins
FEops HEARTguide™ simulations provide a detailed preview of how a device will interact with a patient’s anatomy before the procedure. Physicians can determine the optimal size and positioning, reducing complications and improving outcomes. - Going beyond simple anatomical measurements
Unlike manual “rigid-device overlay” techniques, FEops offers deeper insights into device–anatomy interaction, enabling safer and more precise interventions. - Validated, AI-enabled anatomical analysis
FEops HEARTguide™ is the only stand-alone platform that merges digital twins with AI to provide consistent, quality-controlled data in minutes.
Pipeline Developments
- Expanding to new interventions
Beyond TAVI and LAAo planning, FEops is developing personalized simulations for transcatheter tricuspid valve replacement (TTVR) and other structural heart therapies. - Enhancing AI algorithms
Continuous improvements deliver faster, more consistent, and more accurate anatomical analyses. - Beyond pre-operative planning
By fusing FEops simulations with live fluoroscopic images inside the cath lab, physicians will soon be able to position devices with unmatched precision during procedures.

Impact
By advancing the United Nations Sustainable Development Goal 3: Good Health and Well-Being, FEops contributes to healthier lives and improved care for patients of all ages. Its cloud-based platform, FEops HEARTguide™, leverages predictive simulation to give clinicians and medical device manufacturers unprecedented preoperative insights into how transcatheter structural heart devices will interact with a patient’s unique anatomy. This innovation supports safer procedures, more effective treatments, and better patient outcomes.

Leveraging the 3DEXPERIENCE platform
The 3DEXPERIENCE platform provides FEops with the tools needed to scale and optimize its solution. Its on-demand, cloud-based software and hardware ensure seamless and efficient delivery of FEops HEARTguide™ to clinicians worldwide. Advanced 3D multiphysics simulation enables the most accurate and personalized predictive insights into patient-specific device–heart interactions. In addition, the platform offers the potential to integrate data science and machine learning into FEops HEARTguide™ workflows, significantly reducing turnaround times and enhancing overall efficiency.

FEops
FEops is a medtech company advancing personalized care in structural heart disease through predictive simulations. Its cloud-based platform, FEops HEARTguide™, helps clinicians and device manufacturers optimize treatment planning, improve patient outcomes, and accelerate innovation.
Meet the Team
Explore Our Portfolio
Submit Your Application
Interested? Take your chance to elevate your project to the next level.